Outcomes in adults with NAFLD

Given the growing importance of NAFLD and its inflammatory manifestation, in a new prospective study from the NASH Clinical Research Network, A. J. Sanyal et al. describe outcomes for 1773 adults with biopsy-proven NAFLD with an average follow-up period of 4 years...
PUBLISHED IN: N Engl J Med 2021

Commentary

Given the growing importance of NAFLD and its inflammatory manifestation, in a new prospective study from the NASH Clinical Research Network, A. J. Sanyal et al. describe outcomes for 1773 adults with biopsy-proven NAFLD with an average follow-up period of 4 years.

At baseline, 25% of patients had NAFLD without NASH, and 75% had borderline or definite NASH. During follow-up, mortality and incidence of hepatic decompensation events were progressively higher across fibrosis stage at baseline. Fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death.

Share the article
Avatar photo

Dr. G. Bozet, MD

Articles: 174

Leave a Reply

Your email address will not be published. Required fields are marked *

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES